Global Kidney Cancer Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Kidney Cancer market is projected to reach US$ 703.7 million by 2028 from an estimated US$ 487.2 million in 2022, at a CAGR of 6.3% during 2023 and 2028.

Global key players of Kidney Cancer include Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, etc. Global top four manufacturers hold a share over 35%. North America has the largest number of Kidney cancer, holds a share of about 50%. In terms of product, targeted therapy is the largest segment, with a share over 45%. And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Kidney Cancer.

The Kidney Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Kidney Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck

Novartis

Bristol-Myers Squibb

Pfizer

Roche

Amgen

Aveo Pharmaceuticals

Bayer

Exelixis

Eisai

Product Type Insights

Global markets are presented by Kidney Cancer type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Kidney Cancer are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Surgery

Immunotherapy

Targeted Therapy

Other

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Kidney Cancer market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Kidney Cancer market.

Renal Cell Carcinoma

Renal Pelvis Cancer

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Kidney Cancer market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Kidney Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Kidney Cancer industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Cancer.

1.1 Kidney Cancer Product Introduction

1.2 Market by Type

1.2.1 Global Kidney Cancer Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Surgery

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Kidney Cancer Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 Renal Cell Carcinoma

1.3.3 Renal Pelvis Cancer

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Kidney Cancer Market Size Estimates and Forecasts

2.2 Kidney Cancer Market Size by Region: 2022 Versus 2028

2.2.1 Global Kidney Cancer Revenue by Region: 2017-2022

2.2.2 Global Kidney Cancer Revenue Forecast by Region (2023-2028)

2.2.3 Global Kidney Cancer Revenue Market Share by Region (2017-2028)

3.1 Global Kidney Cancer Revenue by Company (2017-2022)

3.2 Global Kidney Cancer Revenue Share by Company (2017-2022)

3.3 Competitive Landscape

3.3.1 Key Kidney Cancer Companies around the World: Ranking by Revenue

3.3.2 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.3.3 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Kidney Cancer Companies Headquarters & Product Type

3.4.1 Kidney Cancer Companies Headquarters

3.4.2 Global Kidney Cancer Companies Product & Service

3.4.3 Date of International Companies Enter into Kidney Cancer Market

3.5 Global Kidney Cancer Mergers & Acquisitions, Expansion Plans

4.1 Merck

4.1.1 Merck Corporation Information

4.1.2 Merck Description, Business Overview

4.1.3 Merck Kidney Cancer Products Offered

4.1.4 Merck Kidney Cancer Revenue and Gross Margin (2017-2022)

4.1.5 Merck Kidney Cancer Revenue by Product in 2021

4.1.6 Merck Kidney Cancer Revenue by Application in 2021

4.1.7 Merck Kidney Cancer Revenue by Geographic Area in 2021

4.1.8 Merck Recent Developments

4.2 Novartis

4.2.1 Novartis Corporation Information

4.2.2 Novartis Description, Business Overview

4.2.3 Novartis Kidney Cancer Products Offered

4.2.4 Novartis Kidney Cancer Revenue and Gross Margin (2017-2022)

4.2.5 Novartis Kidney Cancer Revenue by Product in 2021

4.2.6 Novartis Kidney Cancer Revenue by Application in 2021

4.2.7 Novartis Kidney Cancer Revenue by Geographic Area in 2021

4.2.8 Novartis Recent Developments

4.3 Bristol-Myers Squibb

4.3.1 Bristol-Myers Squibb Corporation Information

4.3.2 Bristol-Myers Squibb Description, Business Overview

4.3.3 Bristol-Myers Squibb Kidney Cancer Products Offered

4.3.4 Bristol-Myers Squibb Kidney Cancer Revenue and Gross Margin (2017-2022)

4.3.5 Bristol-Myers Squibb Kidney Cancer Revenue by Product in 2021

4.3.6 Bristol-Myers Squibb Kidney Cancer Revenue by Application in 2021

4.3.7 Bristol-Myers Squibb Kidney Cancer Revenue by Geographic Area in 2021

4.3.8 Bristol-Myers Squibb Recent Developments

4.4 Pfizer

4.4.1 Pfizer Corporation Information

4.4.2 Pfizer Description, Business Overview

4.4.3 Pfizer Kidney Cancer Products Offered

4.4.4 Pfizer Kidney Cancer Revenue and Gross Margin (2017-2022)

4.4.5 Pfizer Kidney Cancer Revenue by Product in 2021

4.4.6 Pfizer Kidney Cancer Revenue by Application in 2021

4.4.7 Pfizer Kidney Cancer Revenue by Geographic Area in 2021

4.4.8 Pfizer Recent Developments

4.5 Roche

4.5.1 Roche Corporation Information

4.5.2 Roche Description, Business Overview

4.5.3 Roche Kidney Cancer Products Offered

4.5.4 Roche Kidney Cancer Revenue and Gross Margin (2017-2022)

4.5.5 Roche Kidney Cancer Revenue by Product in 2021

4.5.6 Roche Kidney Cancer Revenue by Application in 2021

4.5.7 Roche Kidney Cancer Revenue by Geographic Area in 2021

4.5.8 Roche Recent Developments

4.6 Amgen

4.6.1 Amgen Corporation Information

4.6.2 Amgen Description, Business Overview

4.6.3 Amgen Kidney Cancer Products Offered

4.6.4 Amgen Kidney Cancer Revenue and Gross Margin (2017-2022)

4.6.5 Amgen Kidney Cancer Revenue by Product in 2021

4.6.6 Amgen Kidney Cancer Revenue by Application in 2021

4.6.7 Amgen Kidney Cancer Revenue by Geographic Area in 2021

4.6.8 Amgen Recent Development

4.7 Aveo Pharmaceuticals

4.7.1 Aveo Pharmaceuticals Corporation Information

4.7.2 Aveo Pharmaceuticals Description, Business Overview

4.7.3 Aveo Pharmaceuticals Kidney Cancer Products Offered

4.7.4 Aveo Pharmaceuticals Kidney Cancer Revenue and Gross Margin (2017-2022)

4.7.5 Aveo Pharmaceuticals Kidney Cancer Revenue by Product in 2021

4.7.6 Aveo Pharmaceuticals Kidney Cancer Revenue by Application in 2021

4.7.7 Aveo Pharmaceuticals Kidney Cancer Revenue by Geographic Area in 2021

4.7.8 Aveo Pharmaceuticals Recent Development

4.8 Bayer

4.8.1 Bayer Corporation Information

4.8.2 Bayer Description, Business Overview

4.8.3 Bayer Kidney Cancer Products Offered

4.8.4 Bayer Kidney Cancer Revenue and Gross Margin (2017-2022)

4.8.5 Bayer Kidney Cancer Revenue by Product in 2021

4.8.6 Bayer Kidney Cancer Revenue by Application in 2021

4.8.7 Bayer Kidney Cancer Revenue by Geographic Area in 2021

4.8.8 Bayer Recent Development

4.9 Exelixis

4.9.1 Exelixis Corporation Information

4.9.2 Exelixis Description, Business Overview

4.9.3 Exelixis Kidney Cancer Products Offered

4.9.4 Exelixis Kidney Cancer Revenue and Gross Margin (2017-2022)

4.9.5 Exelixis Kidney Cancer Revenue by Product in 2021

4.9.6 Exelixis Kidney Cancer Revenue by Application in 2021

4.9.7 Exelixis Kidney Cancer Revenue by Geographic Area in 2021

4.9.8 Exelixis Recent Development

4.10 Eisai

4.10.1 Eisai Corporation Information

4.10.2 Eisai Description, Business Overview

4.10.3 Eisai Kidney Cancer Products Offered

4.10.4 Eisai Kidney Cancer Revenue and Gross Margin (2017-2022)

4.10.5 Eisai Kidney Cancer Revenue by Product in 2021

4.10.6 Eisai Kidney Cancer Revenue by Application in 2021

4.10.7 Eisai Kidney Cancer Revenue by Geographic Area in 2021

4.10.8 Eisai Recent Development

5.1 Global Kidney Cancer Revenue by Type (2017-2022)

5.2 Global Kidney Cancer Revenue Forecast by Type (2023-2028)

5.3 Kidney Cancer Revenue Marke Share by Type (2017-2028)

6.1 Global Kidney Cancer Revenue by Application (2017-2022)

6.2 Global Kidney Cancer Revenue Forecast by Application (2023-2028)

6.3 Kidney Cancer Revenue Market Share by Application (2017-2028)

7.1 North America Kidney Cancer Market Size YoY Growth 2017-2028

7.2 North America Kidney Cancer Market Facts & Figures by Country (2017-2028)

7.3 North America Kidney Cancer Revenue by Type (2017-2022)

7.4 North America Kidney Cancer Revenue by Application (2017-2022)

8.1 Asia-Pacific Kidney Cancer Market Size YoY Growth 2017-2028

8.2 Asia-Pacific Kidney Cancer Market Facts & Figures by Region (2017-2028)

8.3 Asia-Pacific Kidney Cancer Revenue by Type (2017-2022)

8.4 Asia-Pacific Kidney Cancer Revenue by Application (2017-2022)

9.1 Europe Kidney Cancer Market Size YoY Growth 2017-2028

9.2 Europe Kidney Cancer Market Facts & Figures by Country (2017-2028)

9.3 Europe Kidney Cancer Revenue by Type (2017-2022)

9.4 Europe Kidney Cancer Revenue by Application (2017-2022)

10.1 Latin America Kidney Cancer Market Size YoY Growth 2017-2028

10.2 Latin America Kidney Cancer Market Facts & Figures by Country (2017-2028)

10.3 Latin America Kidney Cancer Revenue by Type (2017-2022)

10.4 Latin America Kidney Cancer Revenue by Application (2017-2022)

11.1 Middle East and Africa Kidney Cancer Market Size YoY Growth 2017-2028

11.2 Middle East and Africa Kidney Cancer Market Facts & Figures by Country (2017-2028)

11.3 Middle East and Africa Kidney Cancer Revenue by Type (2017-2022)

11.4 Middle East and Africa Kidney Cancer Revenue by Application (2017-2022)

12.1 Kidney Cancer Supply Chain Analysis

12.2 Kidney Cancer Key Raw Materials and Upstream Suppliers

12.3 Kidney Cancer Clients Analysis

12.4 Kidney Cancer Sales Channel and Sales Model Analysis

12.4.1 Kidney Cancer Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Kidney Cancer Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Kidney Cancer Distributors

13.1 Kidney Cancer Industry Trends

13.2 Kidney Cancer Market Drivers

13.3 Kidney Cancer Market Challenges

13.4 Kidney Cancer Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Companies of Surgery

    Table 3. Major Companies of Immunotherapy

    Table 4. Major Companies of Targeted Therapy

    Table 5. Major Companies of Other

    Table 6. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Kidney Cancer Market Size by Region (US$ Million): 2022 VS 2028

    Table 8. Global Kidney Cancer Revenue by Region (2017-2022) & (US$ Million)

    Table 9. Global Kidney Cancer Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 10. Kidney Cancer Revenue by Company (2017-2022) & (US$ Million)

    Table 11. Kidney Cancer Revenue Share by Company (2017-2022)

    Table 12. Ranking of Global Top Kidney Cancer Players by Revenue (US$ Million) in 2021

    Table 13. Global Kidney Cancer Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 14. Global Kidney Cancer by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Cancer as of 2021)

    Table 15. Global Kidney Cancer Companies Headquarters

    Table 16. Global Kidney Cancer Companies Product & Service

    Table 17. Date of International Companies Enter into Kidney Cancer Market

    Table 18. Global Kidney Cancer Mergers & Acquisitions, Expansion Plans

    Table 19. Merck Corporation Information

    Table 20. Merck Description and Business Overview

    Table 21. Merck Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 22. Merck Kidney Cancer Product

    Table 23. Merck Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 24. Merck Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 25. Merck Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 26. Merck Recent Development

    Table 27. Novartis Corporation Information

    Table 28. Novartis Description and Business Overview

    Table 29. Novartis Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 30. Novartis Kidney Cancer Product

    Table 31. Novartis Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 32. Novartis Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 33. Novartis Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 34. Novartis Recent Development

    Table 35. Bristol-Myers Squibb Corporation Information

    Table 36. Bristol-Myers Squibb Description and Business Overview

    Table 37. Bristol-Myers Squibb Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 38. Bristol-Myers Squibb Kidney Cancer Product

    Table 39. Bristol-Myers Squibb Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 40. Bristol-Myers Squibb Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 41. Bristol-Myers Squibb Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 42. Bristol-Myers Squibb Recent Development

    Table 43. Pfizer Corporation Information

    Table 44. Pfizer Description and Business Overview

    Table 45. Pfizer Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 46. Pfizer Kidney Cancer Product

    Table 47. Pfizer Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 48. Pfizer Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 49. Pfizer Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 50. Pfizer Recent Development

    Table 51. Roche Corporation Information

    Table 52. Roche Description and Business Overview

    Table 53. Roche Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 54. Roche Kidney Cancer Product

    Table 55. Roche Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 56. Roche Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 57. Roche Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 58. Roche Recent Development

    Table 59. Amgen Corporation Information

    Table 60. Amgen Description and Business Overview

    Table 61. Amgen Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 62. Amgen Kidney Cancer Product

    Table 63. Amgen Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 64. Amgen Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 65. Amgen Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 66. Aveo Pharmaceuticals Corporation Information

    Table 67. Aveo Pharmaceuticals Description and Business Overview

    Table 68. Aveo Pharmaceuticals Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 69. Aveo Pharmaceuticals Kidney Cancer Product

    Table 70. Aveo Pharmaceuticals Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 71. Aveo Pharmaceuticals Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 72. Aveo Pharmaceuticals Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 73. Bayer Corporation Information

    Table 74. Bayer Description and Business Overview

    Table 75. Bayer Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 76. Bayer Kidney Cancer Product

    Table 77. Bayer Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 78. Bayer Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 79. Bayer Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 80. Exelixis Corporation Information

    Table 81. Exelixis Description and Business Overview

    Table 82. Exelixis Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 83. Exelixis Kidney Cancer Product

    Table 84. Exelixis Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 85. Exelixis Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 86. Exelixis Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 87. Eisai Corporation Information

    Table 88. Eisai Description and Business Overview

    Table 89. Eisai Kidney Cancer Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 90. Eisai Kidney Cancer Product

    Table 91. Eisai Kidney Cancer Revenue Proportion of Kidney Cancer by Product in 2021

    Table 92. Eisai Kidney Cancer Revenue Proportion of Kidney Cancer by Application in 2021

    Table 93. Eisai Kidney Cancer Revenue Proportion of Kidney Cancer by Geographic Area in 2021

    Table 94. Global Kidney Cancer Revenue by Type (2017-2022) & (US$ Million)

    Table 95. Global Kidney Cancer Revenue by Application (2017-2022) & (US$ Million)

    Table 96. Global Kidney Cancer Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 97. North America Kidney Cancer Revenue by Country (2017-2022) & (US$ Million)

    Table 98. North America Kidney Cancer Revenue by Country (2023-2028) & (US$ Million)

    Table 99. North America Kidney Cancer Revenue by Type (2017-2022) & (US$ Million)

    Table 100. North America Kidney Cancer Revenue by Application (2017-2022) & (US$ Million)

    Table 101. Asia-Pacific Kidney Cancer Revenue by Region (2017-2028) & (US$ Million)

    Table 102. Asia-Pacific Kidney Cancer Revenue by Region (2023-2028) & (US$ Million)

    Table 103. Asia-Pacific Kidney Cancer Revenue by Type (2017-2022) & (US$ Million)

    Table 104. Asia-Pacific Kidney Cancer Revenue by Application (2017-2022) & (US$ Million)

    Table 105. Europe Kidney Cancer Revenue by Country (2017-2022) & (US$ Million)

    Table 106. Europe Kidney Cancer Revenue by Country (2023-2028) & (US$ Million)

    Table 107. Europe Kidney Cancer Revenue by Type (2017-2022) & (US$ Million)

    Table 108. Europe Kidney Cancer Revenue by Application (2017-2022) & (US$ Million)

    Table 109. Latin America Kidney Cancer Revenue by Country (2017-2022) & (US$ Million)

    Table 110. Latin America Kidney Cancer Revenue by Country (2023-2028) & (US$ Million)

    Table 111. Latin America Kidney Cancer Revenue by Type (2017-2022) & (US$ Million)

    Table 112. Latin America Kidney Cancer Revenue by Application (2017-2022) & (US$ Million)

    Table 113. Middle East and Africa Kidney Cancer Revenue by Country (2017-2022) & (US$ Million)

    Table 114. Middle East and Africa Kidney Cancer Revenue by Country (2023-2028) & (US$ Million)

    Table 115. Middle East and Africa Kidney Cancer Revenue by Type (2017-2022) & (US$ Million)

    Table 116. Middle East and Africa Kidney Cancer Revenue by Application (2017-2022) & (US$ Million)

    Table 117. Kidney Cancer Key Raw Materials, Industry Status and Trend

    Table 118. Kidney Cancer Key Raw Materials and Upstream Suppliers

    Table 119. Kidney Cancer Clients Status and Trend

    Table 120. Kidney Cancer Typical Clients

    Table 121. Kidney Cancer Distributors

    Table 122. Kidney Cancer Market Trends

    Table 123. Kidney Cancer Market Drivers

    Table 124. Kidney Cancer Market Challenges

    Table 125. Kidney Cancer Market Restraints

    Table 126. Research Programs/Design for This Report

    Table 127. Key Data Information from Secondary Sources

    Table 128. Key Data Information from Primary Sources

List of Figures

    Figure 1. Kidney Cancer Product Picture

    Figure 2. Global Kidney Cancer Revenue Market Share by Type in 2021 & 2028

    Figure 3. Surgery Product Picture

    Figure 4. Immunotherapy Product Picture

    Figure 5. Targeted Therapy Product Picture

    Figure 6. Other Product Picture

    Figure 7. Global Kidney Cancer Revenue Market Share by Application in 2021 & 2028

    Figure 8. Renal Cell Carcinoma

    Figure 9. Renal Pelvis Cancer

    Figure 10. Other

    Figure 11. Kidney Cancer Report Years Considered

    Figure 12. Global Kidney Cancer Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 13. Global Kidney Cancer Market Size 2017-2028 (US$ Million)

    Figure 14. Global Kidney Cancer Market Size Market Share by Region: 2022 Versus 2028

    Figure 15. Global Kidney Cancer Revenue Market Share by Region (2017-2028)

    Figure 16. Kidney Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 17. Global Kidney Cancer Revenue Market Share Forecast by Type (2017-2028)

    Figure 18. Global Kidney Cancer Revenue Market Share Forecast by Application (2017-2028)

    Figure 19. North America Kidney Cancer Revenue 2017-2028 (US$ Million)

    Figure 20. North America Kidney Cancer Revenue Market Share by Type (2017-2022)

    Figure 21. North America Kidney Cancer Revenue Market Share by Application (2017-2022)

    Figure 22. Asia-Pacific Kidney Cancer Revenue 2017-2028 (US$ Million)

    Figure 23. Asia-Pacific Kidney Cancer Revenue Market Share by Region (2017-2028)

    Figure 24. Asia-Pacific Kidney Cancer Revenue Market Share by Type (2017-2022)

    Figure 25. Asia-Pacific Kidney Cancer Revenue Market Share by Application (2017-2022)

    Figure 26. Europe Kidney Cancer Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 27. Europe Kidney Cancer Revenue Market Share by Country (2017-2028)

    Figure 28. Europe Kidney Cancer Revenue Market Share by Type (2017-2022)

    Figure 29. Europe Kidney Cancer Revenue Market Share by Application (2017-2022)

    Figure 30. Latin America Kidney Cancer Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 31. Latin America Kidney Cancer Revenue Market Share by Country (2017-2022)

    Figure 32. Latin America Kidney Cancer Revenue Market Share by Type (2017-2022)

    Figure 33. Latin America Kidney Cancer Revenue Market Share by Application (2017-2022)

    Figure 34. Middle East and Africa Kidney Cancer Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 35. Middle East and Africa Kidney Cancer Revenue Market Share by Country (2017-2028)

    Figure 36. Middle East and Africa Kidney Cancer Revenue Market Share by Type (2017-2022)

    Figure 37. Middle East and Africa Kidney Cancer Revenue Market Share by Application (2017-2022)

    Figure 38. Kidney Cancer Supply Chain (Upstream and Downstream Market)

    Figure 39. Global Production Market Share of Kidney Cancer Raw Materials by Region in 2021

    Figure 40. Kidney Cancer Distribution Channels

    Figure 41. Global Kidney Cancer Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 42. Global Kidney Cancer Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 43. Bottom-up and Top-down Approaches for This Report

    Figure 44. Data Triangulation

    Figure 45. Key Executives Interviewed